The only program of its kind in Alabama, UABTeach enables undergraduate STEM majors to receive a subject-matter degree and accreditation to teach at the secondary level in a traditional four-year plan.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
Nathaniel Lawson, DMD, assistant professor at the University of Alabama Birmingham School of Dentistry, is the recipient of the 2015 John W. Stanford New Investigator Award given by the American Dental Association.
Gift from United Therapeutics will establish Xenotransplantation Institute and bring additional resources to support the endeavor with a goal of genetically modified kidney transplants taking place by 2021.